Kerri Ann Millar is CHIEF FINANCIAL OFFICER of Cue Biopharma, Inc.. Currently has a direct ownership of 14,311 shares of CUE, which is worth approximately $21,752. The most recent transaction as insider was on Aug 22, 2022, when has been sold 2,828 shares (Common Stock) at a price of $3.05 per share, resulting in proceeds of $8,625. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.3K
0% 3M change
0% 12M change
Total Value Held $21,752

Kerri-Ann Millar Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 22 2022
SELL
Payment of exercise price or tax liability
$8,625 $3.05 p/Share
2,828 Reduced 16.5%
14,311 Common Stock
Aug 21 2022
BUY
Exercise of conversion of derivative security
-
6,667 Added 28.01%
17,139 Common Stock
Oct 01 2021
SELL
Open market or private sale
$17,777 $14.21 p/Share
1,251 Reduced 10.67%
10,472 Common Stock
Oct 01 2021
BUY
Exercise of conversion of derivative security
$9,382 $7.5 p/Share
1,251 Added 9.64%
11,723 Common Stock
Aug 23 2021
SELL
Payment of exercise price or tax liability
-
1,961 Reduced 15.77%
10,472 Common Stock
Aug 23 2021
BUY
Exercise of conversion of derivative security
-
6,667 Added 34.91%
12,433 Common Stock
KM

Kerri Ann Millar

CHIEF FINANCIAL OFFICER
Boston, MA

Track Institutional and Insider Activities on CUE

Follow Cue Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CUE shares.

Notify only if

Insider Trading

Get notified when an Cue Biopharma, Inc. insider buys or sells CUE shares.

Notify only if

News

Receive news related to Cue Biopharma, Inc.

Track Activities on CUE